Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Diabetes|February 2, 2011
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patientsSimonetta Bacci, Stefano Rizza, Sabrina Prudente, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2021
Gain of Function of Malate Dehydrogenase 2 and Familial HyperglycemiaPrapaporn Jungtrakoon Thamtarana, Antonella Marucci, Luca Pannone, et al.
Nature Medicine|April 24, 2019
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetesMonika A Niewczas, Meda E Pavkov, Jan Skupien, et al.
Cell Metabolism|December 25, 2015
SerpinB1 Promotes Pancreatic β Cell ProliferationAbdelfattah El Ouaamari, Ercument Dirice, Nicholas Gedeon, et al.
Diabetes & Metabolism|April 29, 2022
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetesSerena Pezzilli, Manoush Tohidirad, Tommaso Biagini, et al.
Diabetes|January 25, 2020
PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-LipidMario Luca Morieri, Hetal S Shah, Jennifer Sjaarda, et al.
Diabetes|March 3, 2009
Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetesMarcus G Pezzolesi, G David Poznik, Josyf C Mychaleckyj, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2015
Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers ConsortiumChi-Yuan Hsu, Shawn Ballard, Daniel Batlle, et al.
The Journal of Clinical Investigation|April 4, 2023
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathyFabian Braun, Ahmed Abed, Dominik Sellung, et al.
Diabetes|July 10, 2013
Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetesHanieh Yaghootkar, Claudia Lamina, Robert A Scott, et al.
Pageof 25